Oren Gilad insider trades

Open-market stock purchases and sales by Oren Gilad, President/CEO at Aprea Therapeutics, Inc, from SEC Form 4 filings since Jul 28, 2022.

Track record: 0% of 8 scored buys are up 5% or more since purchase, averaging -60%.

Recent trades

DateStockTradeValue
Mar 12, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Mar 12, 2026APRE Aprea Therapeutics, IncBought (not open market)—
Jan 30, 2026APRE Aprea Therapeutics, IncBought$21.5K
Dec 10, 2025APRE Aprea Therapeutics, IncBought$22.3K

Companies traded

  • APRE Aprea Therapeutics, Inc: 10 buys, last Mar 12, 2026

Get free alerts when Oren Gilad files a new trade →